Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF652
|
ENSG00000198740.4 | zinc finger protein 652 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_47439754_47440260 | ZNF652 | 172 | 0.920696 | 0.58 | 1.0e-01 | Click! |
chr17_47437068_47437219 | ZNF652 | 2335 | 0.197885 | 0.42 | 2.6e-01 | Click! |
chr17_47436072_47436225 | ZNF652 | 3330 | 0.160417 | -0.20 | 6.1e-01 | Click! |
chr17_47435658_47435809 | ZNF652 | 3745 | 0.152399 | -0.19 | 6.3e-01 | Click! |
chr17_47436272_47436423 | ZNF652 | 3131 | 0.165365 | -0.08 | 8.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_68871678_68872325 | 1.14 |
CORO2B |
coronin, actin binding protein, 2B |
428 |
0.9 |
chr1_157979573_157979761 | 1.13 |
KIRREL-IT1 |
KIRREL intronic transcript 1 (non-protein coding) |
15673 |
0.2 |
chr4_114899439_114899761 | 0.90 |
ARSJ |
arylsulfatase family, member J |
552 |
0.84 |
chr1_33167770_33168186 | 0.89 |
SYNC |
syncoilin, intermediate filament protein |
383 |
0.81 |
chr11_131780111_131780399 | 0.83 |
NTM |
neurotrimin |
642 |
0.77 |
chr9_132935666_132935932 | 0.83 |
NCS1 |
neuronal calcium sensor 1 |
942 |
0.6 |
chr22_37957123_37957770 | 0.83 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
959 |
0.43 |
chr9_684288_685148 | 0.79 |
RP11-130C19.3 |
|
837 |
0.67 |
chr2_217235630_217236249 | 0.78 |
MARCH4 |
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase |
811 |
0.59 |
chr3_64670816_64671530 | 0.76 |
ADAMTS9-AS2 |
ADAMTS9 antisense RNA 2 |
369 |
0.87 |
chr19_41724924_41725075 | 0.72 |
AXL |
AXL receptor tyrosine kinase |
109 |
0.94 |
chr7_83823215_83823431 | 0.72 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
894 |
0.76 |
chr6_6006212_6006448 | 0.72 |
NRN1 |
neuritin 1 |
870 |
0.69 |
chr4_7873664_7873998 | 0.70 |
AFAP1 |
actin filament associated protein 1 |
22 |
0.98 |
chr19_15218875_15219085 | 0.69 |
SYDE1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
664 |
0.57 |
chrX_70365452_70365975 | 0.67 |
NLGN3 |
neuroligin 3 |
1001 |
0.39 |
chr1_149908154_149908323 | 0.67 |
MTMR11 |
myotubularin related protein 11 |
5 |
0.95 |
chr6_86161250_86161444 | 0.65 |
NT5E |
5'-nucleotidase, ecto (CD73) |
1520 |
0.52 |
chr16_54407600_54408115 | 0.64 |
IRX3 |
iroquois homeobox 3 |
87182 |
0.09 |
chr5_39424091_39424274 | 0.64 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
788 |
0.75 |
chr1_163040363_163040678 | 0.63 |
RGS4 |
regulator of G-protein signaling 4 |
1314 |
0.56 |
chr15_49189463_49189709 | 0.63 |
EID1 |
EP300 interacting inhibitor of differentiation 1 |
19253 |
0.15 |
chr4_158143735_158144020 | 0.62 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
1059 |
0.6 |
chr12_54403531_54403974 | 0.62 |
HOXC8 |
homeobox C8 |
920 |
0.28 |
chr3_129322543_129322829 | 0.61 |
PLXND1 |
plexin D1 |
2975 |
0.23 |
chr7_92325122_92325607 | 0.60 |
ENSG00000206763 |
. |
5764 |
0.28 |
chr8_16858288_16858475 | 0.60 |
FGF20 |
fibroblast growth factor 20 |
968 |
0.64 |
chr14_52122113_52122363 | 0.60 |
FRMD6 |
FERM domain containing 6 |
3540 |
0.25 |
chr4_20252886_20253037 | 0.60 |
SLIT2 |
slit homolog 2 (Drosophila) |
1922 |
0.5 |
chr13_38172711_38172913 | 0.60 |
POSTN |
periostin, osteoblast specific factor |
51 |
0.99 |
chr15_33011706_33011883 | 0.60 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
1589 |
0.4 |
chr1_178341100_178341570 | 0.60 |
RASAL2 |
RAS protein activator like 2 |
30729 |
0.22 |
chr18_29929931_29930163 | 0.59 |
RP11-344B2.2 |
|
62647 |
0.1 |
chr19_45995836_45996758 | 0.59 |
RTN2 |
reticulon 2 |
228 |
0.87 |
chr7_41741617_41741923 | 0.59 |
INHBA |
inhibin, beta A |
936 |
0.57 |
chr12_76376819_76377254 | 0.58 |
ENSG00000243420 |
. |
25126 |
0.18 |
chr5_58592476_58593460 | 0.58 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
21023 |
0.29 |
chr13_80707220_80707565 | 0.58 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
206402 |
0.03 |
chr3_112931196_112931871 | 0.58 |
BOC |
BOC cell adhesion associated, oncogene regulated |
124 |
0.97 |
chr6_169651553_169651725 | 0.58 |
THBS2 |
thrombospondin 2 |
607 |
0.82 |
chr8_122652196_122652655 | 0.57 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
283 |
0.88 |
chr10_20104250_20104504 | 0.57 |
PLXDC2 |
plexin domain containing 2 |
791 |
0.65 |
chr6_21597329_21597632 | 0.56 |
SOX4 |
SRY (sex determining region Y)-box 4 |
3409 |
0.4 |
chr11_111606115_111606547 | 0.55 |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
19431 |
0.17 |
chr1_162601208_162601447 | 0.55 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
164 |
0.96 |
chr10_114717886_114718131 | 0.55 |
RP11-57H14.2 |
|
6374 |
0.23 |
chr5_72746721_72747193 | 0.54 |
FOXD1 |
forkhead box D1 |
2605 |
0.29 |
chr4_114898627_114898871 | 0.54 |
ARSJ |
arylsulfatase family, member J |
1403 |
0.54 |
chr7_94025115_94025296 | 0.54 |
COL1A2 |
collagen, type I, alpha 2 |
1332 |
0.57 |
chr9_104248314_104249564 | 0.54 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr15_39875260_39875463 | 0.54 |
THBS1 |
thrombospondin 1 |
2067 |
0.32 |
chr5_58883529_58883730 | 0.54 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
1304 |
0.62 |
chr9_127542045_127542469 | 0.53 |
OLFML2A |
olfactomedin-like 2A |
2707 |
0.2 |
chr15_40395062_40395658 | 0.53 |
BMF |
Bcl2 modifying factor |
2927 |
0.21 |
chr19_11650036_11650336 | 0.52 |
CNN1 |
calponin 1, basic, smooth muscle |
332 |
0.77 |
chr5_171880596_171880995 | 0.52 |
SH3PXD2B |
SH3 and PX domains 2B |
567 |
0.79 |
chr1_118679016_118679244 | 0.51 |
SPAG17 |
sperm associated antigen 17 |
48716 |
0.18 |
chr2_138722074_138722590 | 0.51 |
HNMT |
histamine N-methyltransferase |
289 |
0.95 |
chr9_21591325_21591685 | 0.51 |
MIR31HG |
MIR31 host gene (non-protein coding) |
31837 |
0.16 |
chr16_53242760_53242944 | 0.51 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
489 |
0.82 |
chr1_14924992_14926197 | 0.51 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr10_118131493_118131678 | 0.51 |
CCDC172 |
coiled-coil domain containing 172 |
47645 |
0.15 |
chr12_118626563_118627015 | 0.51 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr13_36044705_36044856 | 0.51 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
6052 |
0.22 |
chr2_197832046_197832264 | 0.50 |
ANKRD44 |
ankyrin repeat domain 44 |
33071 |
0.18 |
chr2_240230661_240230844 | 0.50 |
HDAC4 |
histone deacetylase 4 |
155 |
0.95 |
chr10_123367975_123368278 | 0.50 |
FGFR2 |
fibroblast growth factor receptor 2 |
10154 |
0.3 |
chr8_104311924_104312113 | 0.50 |
FZD6 |
frizzled family receptor 6 |
914 |
0.4 |
chr9_101760960_101761162 | 0.50 |
RP11-92C4.6 |
|
55004 |
0.12 |
chr2_192710503_192710843 | 0.50 |
AC098617.1 |
|
592 |
0.68 |
chr15_38547811_38548278 | 0.50 |
SPRED1 |
sprouty-related, EVH1 domain containing 1 |
2662 |
0.42 |
chr16_31483566_31484168 | 0.50 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
338 |
0.75 |
chr8_89336427_89336652 | 0.50 |
RP11-586K2.1 |
|
2526 |
0.31 |
chr3_13080776_13080942 | 0.49 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
33758 |
0.22 |
chr3_173302672_173303490 | 0.49 |
NLGN1 |
neuroligin 1 |
371 |
0.93 |
chr7_119912542_119912740 | 0.49 |
KCND2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
1081 |
0.69 |
chr4_177711391_177711542 | 0.49 |
VEGFC |
vascular endothelial growth factor C |
2415 |
0.44 |
chr6_17986477_17986974 | 0.49 |
KIF13A |
kinesin family member 13A |
969 |
0.69 |
chr17_12568958_12569229 | 0.49 |
MYOCD |
myocardin |
213 |
0.95 |
chr8_327782_328078 | 0.49 |
FBXO25 |
F-box protein 25 |
28498 |
0.2 |
chr2_11051733_11051998 | 0.49 |
KCNF1 |
potassium voltage-gated channel, subfamily F, member 1 |
198 |
0.95 |
chr18_67957632_67957850 | 0.49 |
SOCS6 |
suppressor of cytokine signaling 6 |
1604 |
0.46 |
chr8_122650853_122651057 | 0.49 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
578 |
0.78 |
chr19_34359259_34359976 | 0.49 |
ENSG00000240626 |
. |
58913 |
0.13 |
chr17_27135310_27135523 | 0.48 |
FAM222B |
family with sequence similarity 222, member B |
3826 |
0.1 |
chr3_112360025_112360176 | 0.48 |
CCDC80 |
coiled-coil domain containing 80 |
16 |
0.98 |
chr8_23381263_23381439 | 0.48 |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
4967 |
0.2 |
chr3_111762396_111762547 | 0.48 |
TMPRSS7 |
transmembrane protease, serine 7 |
646 |
0.71 |
chr6_45296031_45296221 | 0.48 |
RUNX2 |
runt-related transcription factor 2 |
20 |
0.98 |
chr10_20104545_20104778 | 0.48 |
PLXDC2 |
plexin domain containing 2 |
507 |
0.8 |
chr12_56916241_56916754 | 0.48 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
714 |
0.59 |
chr2_109272345_109272703 | 0.48 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
1015 |
0.59 |
chr1_59246622_59247052 | 0.48 |
JUN |
jun proto-oncogene |
2948 |
0.28 |
chr14_53256007_53256204 | 0.48 |
GNPNAT1 |
glucosamine-phosphate N-acetyltransferase 1 |
2123 |
0.25 |
chr1_32170118_32170299 | 0.47 |
COL16A1 |
collagen, type XVI, alpha 1 |
288 |
0.88 |
chr12_132268914_132269167 | 0.47 |
ENSG00000200516 |
. |
16939 |
0.16 |
chr16_20917162_20917313 | 0.47 |
LYRM1 |
LYR motif containing 1 |
4811 |
0.18 |
chr13_80705528_80705730 | 0.47 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
208165 |
0.03 |
chr15_73976188_73976339 | 0.47 |
CD276 |
CD276 molecule |
44 |
0.98 |
chr4_187066208_187066676 | 0.47 |
FAM149A |
family with sequence similarity 149, member A |
361 |
0.85 |
chr10_88728773_88729195 | 0.47 |
ENSG00000272734 |
. |
49 |
0.52 |
chr3_29324420_29324629 | 0.47 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
1417 |
0.49 |
chr9_694286_694821 | 0.47 |
RP11-130C19.3 |
|
8998 |
0.22 |
chr11_123396070_123396267 | 0.47 |
GRAMD1B |
GRAM domain containing 1B |
176 |
0.97 |
chr1_63590436_63590751 | 0.47 |
ENSG00000252259 |
. |
61528 |
0.14 |
chr9_75486718_75486907 | 0.46 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
81159 |
0.11 |
chr19_19510958_19511314 | 0.46 |
CTB-184G21.3 |
|
2276 |
0.22 |
chr1_156542353_156542656 | 0.46 |
IQGAP3 |
IQ motif containing GTPase activating protein 3 |
172 |
0.9 |
chr3_64252728_64253099 | 0.46 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
742 |
0.75 |
chr3_31402829_31403285 | 0.46 |
ENSG00000238727 |
. |
34372 |
0.23 |
chr1_38412223_38412952 | 0.46 |
INPP5B |
inositol polyphosphate-5-phosphatase, 75kDa |
136 |
0.94 |
chr15_96889520_96889695 | 0.46 |
ENSG00000222651 |
. |
13117 |
0.15 |
chr10_119303944_119304573 | 0.46 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
321 |
0.88 |
chr4_41615256_41615763 | 0.45 |
LIMCH1 |
LIM and calponin homology domains 1 |
16 |
0.99 |
chr22_31226381_31226720 | 0.45 |
OSBP2 |
oxysterol binding protein 2 |
8047 |
0.21 |
chr1_60598955_60599379 | 0.45 |
C1orf87 |
chromosome 1 open reading frame 87 |
59725 |
0.16 |
chr5_95068939_95069254 | 0.45 |
CTD-2154I11.2 |
|
1097 |
0.44 |
chr6_27584810_27585278 | 0.45 |
ENSG00000238648 |
. |
14144 |
0.19 |
chr9_116569857_116570008 | 0.45 |
ENSG00000211556 |
. |
15213 |
0.25 |
chr7_14031804_14031996 | 0.45 |
ETV1 |
ets variant 1 |
850 |
0.71 |
chr4_154144789_154145003 | 0.45 |
TRIM2 |
tripartite motif containing 2 |
19278 |
0.19 |
chr11_89224254_89224444 | 0.45 |
NOX4 |
NADPH oxidase 4 |
50 |
0.99 |
chr5_83679357_83679570 | 0.45 |
EDIL3 |
EGF-like repeats and discoidin I-like domains 3 |
741 |
0.46 |
chr22_18050822_18050973 | 0.45 |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
7747 |
0.18 |
chr6_148593838_148594147 | 0.45 |
SASH1 |
SAM and SH3 domain containing 1 |
552 |
0.78 |
chr7_557703_557916 | 0.45 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
336 |
0.89 |
chr1_114525510_114525669 | 0.45 |
OLFML3 |
olfactomedin-like 3 |
2894 |
0.24 |
chr18_31157392_31158104 | 0.44 |
ASXL3 |
additional sex combs like 3 (Drosophila) |
848 |
0.76 |
chr21_47485234_47485853 | 0.44 |
AP001471.1 |
|
31901 |
0.13 |
chr8_48871781_48871958 | 0.44 |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
0 |
0.95 |
chr14_52518510_52518765 | 0.44 |
NID2 |
nidogen 2 (osteonidogen) |
12967 |
0.2 |
chr11_62207920_62208143 | 0.44 |
CTD-2531D15.4 |
|
13835 |
0.11 |
chr11_101917896_101918104 | 0.43 |
C11orf70 |
chromosome 11 open reading frame 70 |
174 |
0.94 |
chr9_35519229_35519505 | 0.43 |
RUSC2 |
RUN and SH3 domain containing 2 |
19262 |
0.14 |
chr5_171708618_171708769 | 0.43 |
UBTD2 |
ubiquitin domain containing 2 |
2382 |
0.24 |
chr3_64430574_64431219 | 0.43 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
162 |
0.97 |
chr8_11620096_11620296 | 0.43 |
C8orf49 |
chromosome 8 open reading frame 49 |
1300 |
0.37 |
chr1_156092284_156092708 | 0.43 |
LMNA |
lamin A/C |
3455 |
0.14 |
chr10_734164_734382 | 0.43 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
1333 |
0.42 |
chr10_114658565_114658744 | 0.43 |
RP11-57H14.3 |
|
10160 |
0.22 |
chr2_46562973_46563252 | 0.43 |
EPAS1 |
endothelial PAS domain protein 1 |
38571 |
0.18 |
chr17_60896968_60897294 | 0.42 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
11426 |
0.25 |
chr10_104536223_104536534 | 0.42 |
WBP1L |
WW domain binding protein 1-like |
372 |
0.83 |
chr1_26348142_26348482 | 0.42 |
EXTL1 |
exostosin-like glycosyltransferase 1 |
41 |
0.95 |
chr14_85996363_85996664 | 0.42 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
25 |
0.98 |
chr4_157870413_157870730 | 0.42 |
PDGFC |
platelet derived growth factor C |
21484 |
0.21 |
chr7_18550262_18550413 | 0.42 |
HDAC9 |
histone deacetylase 9 |
1401 |
0.57 |
chr2_110657178_110657382 | 0.42 |
LIMS3 |
LIM and senescent cell antigen-like domains 3 |
1012 |
0.67 |
chr5_125839383_125839676 | 0.42 |
RP11-517I3.1 |
|
13466 |
0.2 |
chr10_54073128_54073797 | 0.41 |
PRKG1-AS1 |
PRKG1 antisense RNA 1 |
426 |
0.6 |
chr9_14251177_14251439 | 0.41 |
NFIB |
nuclear factor I/B |
56704 |
0.15 |
chr11_114167265_114167463 | 0.41 |
NNMT |
nicotinamide N-methyltransferase |
721 |
0.72 |
chr13_96295981_96296211 | 0.41 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
579 |
0.79 |
chr2_202483531_202483851 | 0.41 |
ALS2CR11 |
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 |
186 |
0.94 |
chr11_73020571_73021013 | 0.41 |
RP11-800A3.7 |
|
386 |
0.76 |
chr5_83677933_83678221 | 0.41 |
EDIL3 |
EGF-like repeats and discoidin I-like domains 3 |
2127 |
0.33 |
chr15_59730475_59730927 | 0.41 |
FAM81A |
family with sequence similarity 81, member A |
6 |
0.98 |
chr11_118492062_118492969 | 0.41 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
14157 |
0.11 |
chr4_122614681_122615038 | 0.41 |
ANXA5 |
annexin A5 |
3258 |
0.3 |
chr6_27647378_27647849 | 0.41 |
ENSG00000238648 |
. |
48425 |
0.11 |
chr12_64916133_64916380 | 0.41 |
ENSG00000223294 |
. |
53189 |
0.1 |
chr10_114571513_114571789 | 0.41 |
RP11-57H14.4 |
|
11598 |
0.26 |
chr5_6687085_6687491 | 0.41 |
PAPD7 |
PAP associated domain containing 7 |
27430 |
0.2 |
chr10_53992863_53993137 | 0.41 |
PRKG1-AS1 |
PRKG1 antisense RNA 1 |
64675 |
0.13 |
chr6_166400769_166401245 | 0.40 |
ENSG00000252196 |
. |
45178 |
0.17 |
chr3_98609388_98609782 | 0.40 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
10430 |
0.18 |
chr3_187008317_187008468 | 0.40 |
MASP1 |
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
1093 |
0.58 |
chr10_21817344_21817512 | 0.40 |
SKIDA1 |
SKI/DACH domain containing 1 |
2817 |
0.19 |
chr14_97277831_97278087 | 0.40 |
VRK1 |
vaccinia related kinase 1 |
14318 |
0.29 |
chr10_88518871_88519024 | 0.40 |
BMPR1A |
bone morphogenetic protein receptor, type IA |
2540 |
0.23 |
chr3_11623453_11623819 | 0.40 |
VGLL4 |
vestigial like 4 (Drosophila) |
229 |
0.94 |
chr20_50178264_50178663 | 0.40 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
705 |
0.79 |
chr2_111229285_111229460 | 0.40 |
LIMS3 |
LIM and senescent cell antigen-like-containing domain protein 3; Uncharacterized protein; cDNA FLJ59124, highly similar to Particularly interesting newCys-His protein; cDNA, FLJ79109, highly similar to Particularly interesting newCys-His protein |
1021 |
0.37 |
chr7_27749281_27749432 | 0.40 |
TAX1BP1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
29594 |
0.17 |
chr20_43975844_43976401 | 0.40 |
SDC4 |
syndecan 4 |
942 |
0.43 |
chr19_1361236_1361464 | 0.40 |
MUM1 |
melanoma associated antigen (mutated) 1 |
4987 |
0.1 |
chr15_34531260_34531657 | 0.40 |
EMC4 |
ER membrane protein complex subunit 4 |
11562 |
0.14 |
chr12_110637604_110637784 | 0.40 |
IFT81 |
intraflagellar transport 81 homolog (Chlamydomonas) |
75497 |
0.09 |
chr3_160203157_160203402 | 0.40 |
TRIM59 |
tripartite motif containing 59 |
282 |
0.89 |
chr5_167182207_167182383 | 0.39 |
TENM2 |
teneurin transmembrane protein 2 |
287 |
0.93 |
chr4_77703399_77704071 | 0.39 |
RP11-359D14.3 |
|
19382 |
0.18 |
chr4_2960493_2960717 | 0.39 |
NOP14 |
NOP14 nucleolar protein |
4455 |
0.16 |
chr6_21005921_21006145 | 0.39 |
ENSG00000252046 |
. |
12234 |
0.31 |
chr3_32002037_32002228 | 0.39 |
OSBPL10 |
oxysterol binding protein-like 10 |
20660 |
0.19 |
chr9_14096101_14096252 | 0.39 |
NFIB |
nuclear factor I/B |
84615 |
0.11 |
chr11_2847450_2848020 | 0.39 |
KCNQ1-AS1 |
KCNQ1 antisense RNA 1 |
35063 |
0.12 |
chr11_130298713_130298864 | 0.39 |
ADAMTS8 |
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
100 |
0.98 |
chr6_170714674_170714865 | 0.39 |
RP1-140C12.2 |
|
8458 |
0.25 |
chr2_228029012_228029295 | 0.39 |
COL4A3 |
collagen, type IV, alpha 3 (Goodpasture antigen) |
128 |
0.75 |
chr16_73178346_73178497 | 0.39 |
C16orf47 |
chromosome 16 open reading frame 47 |
75 |
0.98 |
chr3_72202274_72202709 | 0.39 |
ENSG00000212070 |
. |
109088 |
0.07 |
chr12_54384773_54384996 | 0.39 |
HOXC6 |
homeobox C6 |
476 |
0.4 |
chr3_4624343_4624494 | 0.39 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
66242 |
0.12 |
chr18_72916001_72916152 | 0.39 |
ZADH2 |
zinc binding alcohol dehydrogenase domain containing 2 |
1392 |
0.5 |
chr17_32581423_32581574 | 0.38 |
CCL2 |
chemokine (C-C motif) ligand 2 |
806 |
0.36 |
chr16_24697486_24697909 | 0.38 |
TNRC6A |
trinucleotide repeat containing 6A |
43319 |
0.18 |
chr21_27443752_27443903 | 0.38 |
APP |
amyloid beta (A4) precursor protein |
18550 |
0.24 |
chr6_16229530_16229681 | 0.38 |
ENSG00000207193 |
. |
2956 |
0.24 |
chr15_95870278_95870659 | 0.38 |
ENSG00000222076 |
. |
418565 |
0.01 |
chr2_24306509_24306660 | 0.38 |
TP53I3 |
tumor protein p53 inducible protein 3 |
597 |
0.61 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.2 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.2 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 0.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.3 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.1 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.5 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.6 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.4 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 1.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.2 | GO:0002669 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.6 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.2 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.3 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.3 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.6 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0090189 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.2 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.0 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.0 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0072205 | collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.3 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.7 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.0 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.2 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 2.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 2.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 3.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.9 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 1.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 1.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 2.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |